Home2022-08-22T13:13:13-06:00
Loading...

Latest News

Health Canada Approves ORLADEYO

June 6th, 2022|

We are thrilled to share BioCryst Pharmaceutical's big announcement: Health Canada has approved their oral, once-daily ORLADEYO® (berotralstat) for the routine prevention of HAE attacks in patients 12

HAEi Advocacy Academy

January 6th, 2022|

HAE International is offering free, online advocacy courses. This extremely comprehensive program is designed to support people with HAE in everyday life. The courses are delivered in small manageable chunks and can

Load More Posts

Support Family Testing

Give valuable insights in HAE science

Hereditary Angioedema (HAE) is a hereditary disorder. It is therefore very important to have other family members tested. To help you in this process HAE International has developed two documents for patients. You can download the documents below:

Support Family Testing – Patient Pack 1

Support Family Testing – Patient Pack 2

Go to Top